RS-127,445

RS-127,445
(IUPAC) ime
	4-(4-fluoro-1-naftil)-6-izopropilpirimidin-2-amin
Klinički podaci
Identifikatori
CAS broj	199864-87-4
ATC kod	nije dodeljen
PubChem	196968
Hemijski podaci
Formula	C17H16FN3
Mol. masa	281.327 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C17H16FN3/c1-10(2)15-9-16(21-17(19)20-15)13-7-8-14(18)12-6-4-3-5-11(12)13/h3-10H,1-2H3,(H2,19,20,21) ; Key: ZZZQXCUPAJFVBN-UHFFFAOYSA-N
Sinonimi	RS-127,445
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

RS-127,445 je lek koji deluje kao potentan i selektivan antagonist na serotoninskom 5-HT_2B receptor, sa oko 1000x selektivnošću u odnosu na blisko srodne 5-HT_2A i 5-HT_2C receptore.^[3] Uloga 5-HT_2B receptora u telu još uvek nije dovoljno razjašnjena, i RS-127,445 je bio korisno oruđe u raščlanjavanju funkcija različitih sistema u kojima je ovaj receptor izražen.^[4]^[5]^[6]

References

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Bonhaus DW, Flippin LA, Greenhouse RJ, Jaime S, Rocha C, Dawson M, Van Natta K, Chang LK, Pulido-Rios T, Webber A, Leung E, Eglen RM, Martin GR. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. British Journal of Pharmacology. 1999 Jul;127(5):1075-82. DOI:10.1038/sj.bjp.0702632 PMID 10455251
↑ Launay JM, Hervé P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nature Medicine. 2002 Oct;8(10):1129-35. DOI:10.1038/nm764 PMID 12244304
↑ Kelly CR, Sharif NA. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line. Journal of Pharmacology and Experimental Therapeutics. 2006 Jun;317(3):1254-61. PMID 16517693
↑ Mbaki Y, Ramage AG. Investigation of the role of 5-HT2 receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat. British Journal of Pharmacology. 2008 Oct;155(3):343-56. PMID 18604238

Spoljašnje veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Bonhaus DW, Flippin LA, Greenhouse RJ, Jaime S, Rocha C, Dawson M, Van Natta K, Chang LK, Pulido-Rios T, Webber A, Leung E, Eglen RM, Martin GR. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. British Journal of Pharmacology. 1999 Jul;127(5):1075-82. DOI:10.1038/sj.bjp.0702632 PMID 10455251

[4] Launay JM, Hervé P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nature Medicine. 2002 Oct;8(10):1129-35. DOI:10.1038/nm764 PMID 12244304

[5] Kelly CR, Sharif NA. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line. Journal of Pharmacology and Experimental Therapeutics. 2006 Jun;317(3):1254-61. PMID 16517693

[6] Mbaki Y, Ramage AG. Investigation of the role of 5-HT2 receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat. British Journal of Pharmacology. 2008 Oct;155(3):343-56. PMID 18604238

[3]

[4]

[5]

[6]

[1]

[2]